Even though almost all U.S.-based cannabis businesses and lots of foreign American Depository Receipts (ADRs) trade within the countertop (OTC), a marijuana that is few are exchanged in the NASDAQ. Some investors choose shares which are noted on the NASDAQ with other exchanges for their increased liquidity and tighter spreads when compared to markets that are over-the-counter. For example, whilst the cannabis industry is continuing to grow in current months and years, uplisting from an OTC market to an established U.S. trade happens to be a advertising achievement for several marijuana that is rising. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis Stocks”)
An number that is increasing of organizations are now being noted on reputable U.S. exchanges instead of being exchanged regarding the OTC market reflecting the quick development of the cannabis industry.
NASDAQ-listed Marijuana shares
The NASDAQ was the very first exchange that is electronic is certainly synonymous with technology and biotechnology. The cannabis businesses regarding the NASDAQ mirror this, plus the greater part of them run within the area that is biotech of industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical purchase, at the time of October 26, 2019, with a dysfunction of the total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is really a biotech business mixed up in manufacturing of medical cannabis drugs. Research and development around Arena’s APD371 may be the primary focus regarding the company’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is just a check that is blank that is in a merger contract with Kalyx Development Inc. Kalyx is a number one owning a home rely upon the regulated cannabis industry in the usa.
- The cannabis industry, specially the part of marijuana and biotech, is attracting significant investor attention.
- Cannabis will be found in brand new medications to treat discomfort and chronic that is many inflammatory, and fibrotic conditions.
- Organizations may also be developing cannabinoid services and products for autism range disorders, schizophrenia, glioma, Tourette syndrome, epileptic problems, Prader-Willi Syndrome (an inherited condition), and amphetamine addiction.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is really a clinical-stage biotechnology business focused on developing and commercializing chemical that is new when it comes to indications of pain and pruritus (itching). Although every one of the firm’s clinical-stage products target opioid receptors, Cara happens to be performing research that is preclinical cannabinoids for the treatment of neuropathic discomfort.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech business. The group’s research, development, and manufacturing are based around cannabis drugs that look for to deal with chronic, inflammatory, fibrotic, as well as other conditions.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is really A canadian cannabis business. The team owns and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to fund its continued expansion but additionally with a partner that is well-established within the advertising of consumer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is really a Boca Raton, Florida-based cannabis business. It distributes many different cannabis usage add-ons and vaporization gear and items to customers that are retail the U.S. and Canada. Also, it operates websites that are e-commerce extra product sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is developing a profile of cannabinoid medications. These medications consist of Sativex to treat spasticity pertaining to sclerosis that is multiple cancer tumors pain and Epidiolex for the treating youth epilepsy. Sativex is commercialized much more compared to a dozen nations away from united states of america and contains gotten regulatory approval in various other nations. Epidiolex received Food And Drug Administration approval as a treatment for Dravet Syndrome and cbdoilrank discount Lennox-Gastaut Syndrome, two kinds of serious, early onset epilepsy without good current treatment options. Other indications show that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is really a clinical-stage biopharmaceutical business that is developing drugs based on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally responsible bio-based management that is pest plant health services and products. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now legal to be used on cannabis plants in the California cultivation market.
Modern Age Beverages Corp. (NASDAQ:NBEV)
New Age Beverages Corp. is really a maker of beverages produced from yerba mate, green tea extract, kombucha, and comparable products. In current months, modern age has expanded its beverage offerings to incorporate CBD infusions aswell, bringing it in to the orbit of cannabis shares.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted in the NASDAQ in might of 2019, rendering it perhaps one of the most current cannabis organizations to record regarding the exchange that is popular. The business happens to be quickly expanding its manufacturing capability that will manage to produce just as much as 113,000 kilograms of item per by the end of 2019 year.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation operates into the enforcement sector. The business’s business operations support drug assessment through hair examples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is yet another entry that is new the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a quick price boost) whenever it announced the production of a fresh Palmetto model of leisure cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical business focused in the growth of cannabinoid-based medications. Therapix’s present pipeline includes services and products targeted to treat Tourette problem and mild impairment that is cognitive.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. had been the very first marijuana-related business to have a preliminary general general public providing (IPO) in america. The Nanaimo, Vancouver company that is island-based on medical cannabis services and products.
Village Farms International (NASDAQ:VFF)
Village Farms Global is considered the most present cannabis stock to begin dealing on the NASDAQ. The business’s shares became designed for trade on February 21, 2019. The organization includes a history that is decades-long greenhouse produce production and it has only recently shifted a number of its focus toward cannabis manufacturing.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is targeted regarding the growth of artificial treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline currently includes two medications being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.